Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer

We retrospectively evaluated if personalized Kampo medicine (PKM) could facilitate CTL responses and clinical benefits induced by personalized peptide vaccination (PPV), in which HLA-matched vaccines were selected and administered based on the preexisting host immunity, for advanced esophageal cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Muroya, Daisuke, Yutani, Shigeru, Shichijo, Shigeki, Yamada, Akira, Sakamoto, Shinjiro, Naito, Masayasu, Okuda, Koji, Morita, Michi, Yamaguchi, Rin, Itoh, Kyogo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040795/
https://www.ncbi.nlm.nih.gov/pubmed/27703488
http://dx.doi.org/10.1155/2016/5929525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040795/
https://www.ncbi.nlm.nih.gov/pubmed/27703488
http://dx.doi.org/10.1155/2016/5929525

Ejemplares similares